Intermittent and Sustained Hypoxia Exacerbate the Neonatal Microglial Inflammatory Response to TLR4 Ligands

Elizabeth A. Kiernan,Alyssa Gardner,Elizabeth A. Langenstroer,Jyoti J. Watters

DOI: https://doi.org/10.1096/fasebj.30.1_supplement.746.1

2016-04-01

The FASEB Journal

Abstract:Chronic intermittent hypoxia (IH) is a hallmark of sleep disordered breathing, a condition that occurs in approximately 2–4% of the pediatric population, and in over 50% of premature infants. IH is characterized by increased reactive oxygen species formation, peripheral and CNS inflammation, neuronal death and neurocognitive deficits. However, although IH alone does not promote neuroinflammation in the neonate to the extent it does in adults, few studies have investigated the possibility that IH may exacerbate the neonatal CNS response to systemic inflammation, a common clinical co‐morbidity, especially in premature infants. In neonatal rats, we tested the hypothesis that IH will prime both the peripheral and central immune system leading to potentiation of inflammation. To test this hypothesis, we exposed P1 rat pups to one night of IH (2 min cycles of 10.5% O2). The following morning the pups were challenged with an intraperitoneal injection of the toll‐like receptor 4 (TLR4) ligand lipopolysaccharide (LPS) for 3 hrs. CD11b+ microglia and macrophages were harvested from the brain and spleen, respectively, and iNOS and IL‐1 beta gene expression was analyzed. Preliminary results demonstrated that IH exposure prior to LPS injection increased microglial (but not spleen macrophage) iNOS mRNA levels compared to LPS alone. These findings were confirmed in vitro by exposing murine N9 and primary microglia to sustained hypoxia (1% O2 for 16 hrs) followed by application of multiple TLR4 ligands (LPS, Hsp60, HMGB1) for 3 hrs. Hypoxia potentiated TLR4‐dependent iNOS and IL‐1b mRNA levels, changes that were consistent with increased transcriptional activation marks at the iNOS gene promoter (trimethylation of histone H3 lysine 4; H3K4me3). Future studies will investigate if similar epigenetic modifications also occur in vivo . These data suggest differential responses of peripheral and CNS macrophage populations to the priming effects of hypoxia, and indicate that the CNS may be more vulnerable. By resolving mechanisms whereby hypoxia primes microglial inflammation, novel therapeutic targets can be identified that may be beneficial to an already susceptible pediatric population. Support or Funding Information This work was supported by NIH R01 HL111598 and NS085226

cell biology,biochemistry & molecular biology,biology